(Q24193019)

intermittent claudication

title

Cilostazol for intermittent claudication (English)

0 references

main subject

1 reference

1 reference

Dimitri P Mikhailidis

5

object named as

Dimitri P Mikhailidis

0 references

Gerard Stansby

6

object named as

Gerard Stansby

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358850%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Rachel Bedenis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358850%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Marlene Stewart

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358850%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Marcus Cleanthis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358850%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Peter Robless

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358850%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Dimitri P Mikhailidis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358850%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

7 June 2020

publication date

31 October 2014

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358850%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358850%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

CD003748

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358850%20AND%20SRC:MED&resulttype=core&format=json

A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Effects of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stress, and inflammatory markers in patients with intermittent claudication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

The effects of cilostazol on exercise-induced ischaemia-reperfusion injury in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

The effects of cilostazol on peripheral neuropathy in diabetic patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

The vascular and biochemical effects of cilostazol in diabetic patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Type 3 phosphodiesterase inhibitors may be protective against cerebrovascular events in patients with claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Effect of cilostazol treatment on adiponectin and soluble CD40 ligand levels in diabetic patients with peripheral arterial occlusion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Effect of cilostazol on arterial stiffness and vascular adhesion molecules in type 2 diabetic patients with metabolic syndrome: a randomised, double-blind, placebo-controlled, crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

The role of cilostazol in the treatment of intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Comparative effects of cilostazol and other therapies for intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Angioplasty (versus non surgical management) for intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Life-style modification in peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Differential impact of cilostazol on restenosis according to implanted stent type (from a pooled analysis of three DECLARE randomized trials).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Antiplatelet therapy in peripheral arterial disease. Consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Analysis of the cilostazol safety database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Cilostazol and atherogenic dyslipidemia: a clinically relevant effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Cilostazol in the management of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Comparison of the effect of cilostazol with aspirin on circulating endothelial progenitor cells and small-dense LDL cholesterol in diabetic patients with cerebral ischemia: a randomized controlled pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Exercise for intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Cilostazol for peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Cilostazol for peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

Cilostazol: a review of its use in intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003748.PUB4

A comparison of cilostazol and pentoxifylline for treating intermittent claudication

21 January 2018

1 reference

12 December 2020

The natural history of claudication: risk to life and limb.

1 reference

12 December 2020

Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial

1 reference

12 December 2020

Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication

1 reference

12 December 2020

Efficacy and safety of cilostazol, a novel phosphodiesterase inhibitor in patients with intermittent claudication

1 reference

12 December 2020

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease

1 reference

12 December 2020

10.1002/14651858.CD003748.PUB4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358850%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25358850%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference